ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Vasectomy Doesn’t Increase Prostate Cancer Risk

July 26, 2002

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997

M.D. Anderson Investigator Gave Drug To Patients Without IND; NCI Probes Incident, To Make Report

July 17, 1981

OCEANS Study: Avastin Shows Tumor Shrinkage in 79 Percent

June 24, 2011

Funding Opportunities listed.

December 5, 2003

Also in this issue: ODAC Votes To Strip Breast Cancer Indication From Avastin

July 23, 2010